Clinical Study
Cardiopulmonary Response to Exercise Testing in People with Chronic Stroke: A Retrospective Study
Table 1
Participant demographics.
| Characteristics n = 62 | Group mean (SD)‡ | Males | Females |
| Sex: male | | 32 | 30 | Age (years) | 62.0 (12.0) | 68.0 (10.5) | 55.0 (11.9)* | Height (m) | 1.7 (0.09) | 1.8 (0.05) | 1.6 (0.05)* | Weight (kg) | 87.7 (18.0) | 92.5 (14.8) | 82.5 (19.9) | Body mass index | 29.3 (5.4) | 28.5 (4.2) | 30.2 (6.5) | Race/ethnicity | | | | African American | 11 | 2 | 9 | Caucasian | 46 | 28 | 18 | Hispanic | 4 | 2 | 2 | Native American | 1 | 0 | 1 | Stroke characteristics | | | | Time (months) after stroke | 61.0 (50.0) | 62.9 (35.9) | 57.9 (61.2) | Right side weakness | 31 | 19 | 12 | Bilateral deficits | 1 | 1 | 0 | LE Fugl-Meyer score | 23.3 (7.2) | 24.7 (6.3) | 21.8 (7.8) | Comorbidities for cardiac risk | | | | Type 2 diabetes mellitus | 21 | 12 | 9 | Current smoker | 0 | 0 | 0 | Overweight (BMI 25.0–29.9) [24] | 25 | 27.5 (1.5) | 27.6 (1.6) | Obese (BMI 30.0 to > 40) [24] | 27 | 33.0 (1.7) | 34.2 (4.6) | Medications: | | | | high blood pressure | 40 | 20 | 20 | beta blockers | 21 | 9 | 12 | calcium channel blockers | 15 | 5 | 10 | ACE inhibitors | 30 | 16 | 14 | hyperlipidemia | 17 | 9 | 8 |
|
|
‡Data are “n” participants of 62 unless indicated by group mean (SD).
|